DIAGNOSIS OF COVID-19 BASED ON ARTIFICIAL INTELLIGENCE MODELS AND PHYSIOLOGICAL SENSORS: REVIEW

Author(s):  
Suha Dalaf Fahad ◽  
Sadik Kamel Gharghan ◽  
Raghad Hassan Hussein

Covid-19 invaded the world very quickly and caused the loss of many lives; maximum emergency was activated all over the world due to its rapid spread. Consequently, it became a huge burden on emergency and intensive care units due to the large number of infected individuals and the inability of the medical staff to deal with patients according to the degree of severity. Covid-19 can be diagnosed based on the artificial intelligence (AI) model. Based on AI, the CT images of the patient’s chest can be analyzed to identify the patient case whether it is normal or he/she has Covid-19. The possibility of employing physiological sensors such as heart rate, temperature, respiratory rate, and SpO2 sensors in diagnosing Covid-19 was investigated. In this paper, several articles which used intelligent techniques and vital signs for diagnosing Covid-19 have been reviewed, classified, and compared. The combination of AI and physiological sensors reading, called AI-PSR, can help the clinician in making the decisions and predicting the occurrence of respiratory failure in Covid-19 patients. The physiological parameters of the Covid-19 patients can be transmitted wirelessly based on a specific wireless technology such as Wi-Fi and Bluetooth to the clinician to avoid direct contact between the patient and the clinician or nursing staff. The outcome of the AI-PSR model leads to the probability of recording and linking data with what will happen later, to avoid respiratory failure, and to help the patient with one of the mechanical ventilation devices.

Electronics ◽  
2021 ◽  
Vol 10 (23) ◽  
pp. 2901
Author(s):  
Lilia Muñoz ◽  
Vladimir Villarreal ◽  
Mel Nielsen ◽  
Yen Caballero ◽  
Inés Sittón-Candanedo ◽  
...  

The rapid spread of SARS-CoV-2 and the consequent global COVID-19 pandemic has prompted the public administrations of different countries to establish health procedures and protocols based on information generated through predictive techniques and models, which, in turn, are based on technology such as artificial intelligence (AI) and machine learning (ML). This article presents some AI tools and computational models used to collaborate in the control and detection of COVID-19 cases. In addition, the main features of the Epidempredict project regarding COVID-19 in Panama are presented. This initiative consists of the planning and design of a digital platform, with cloud-based technology, to manage the ingestion, analysis, visualization and exportation of data regarding the evolution of COVID-19 in Panama. The methodology for the design of predictive algorithms is based on a hybrid model that combines the dynamics associated with population data of an SIR model of differential equations and extrapolation with recurrent neural networks. The technological solution developed suggests that adjustments can be made to the rules implemented in the expert processes that are considered. Furthermore, the resulting information is displayed and explored through user-friendly dashboards, contributing to more meaningful decision-making processes.


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Albert T. Young ◽  
Kristen Fernandez ◽  
Jacob Pfau ◽  
Rasika Reddy ◽  
Nhat Anh Cao ◽  
...  

AbstractArtificial intelligence models match or exceed dermatologists in melanoma image classification. Less is known about their robustness against real-world variations, and clinicians may incorrectly assume that a model with an acceptable area under the receiver operating characteristic curve or related performance metric is ready for clinical use. Here, we systematically assessed the performance of dermatologist-level convolutional neural networks (CNNs) on real-world non-curated images by applying computational “stress tests”. Our goal was to create a proxy environment in which to comprehensively test the generalizability of off-the-shelf CNNs developed without training or evaluation protocols specific to individual clinics. We found inconsistent predictions on images captured repeatedly in the same setting or subjected to simple transformations (e.g., rotation). Such transformations resulted in false positive or negative predictions for 6.5–22% of skin lesions across test datasets. Our findings indicate that models meeting conventionally reported metrics need further validation with computational stress tests to assess clinic readiness.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Xinran Wang ◽  
Liang Wang ◽  
Hong Bu ◽  
Ningning Zhang ◽  
Meng Yue ◽  
...  

AbstractProgrammed death ligand-1 (PD-L1) expression is a key biomarker to screen patients for PD-1/PD-L1-targeted immunotherapy. However, a subjective assessment guide on PD-L1 expression of tumor-infiltrating immune cells (IC) scoring is currently adopted in clinical practice with low concordance. Therefore, a repeatable and quantifiable PD-L1 IC scoring method of breast cancer is desirable. In this study, we propose a deep learning-based artificial intelligence-assisted (AI-assisted) model for PD-L1 IC scoring. Three rounds of ring studies (RSs) involving 31 pathologists from 10 hospitals were carried out, using the current guideline in the first two rounds (RS1, RS2) and our AI scoring model in the last round (RS3). A total of 109 PD-L1 (Ventana SP142) immunohistochemistry (IHC) stained images were assessed and the role of the AI-assisted model was evaluated. With the assistance of AI, the scoring concordance across pathologists was boosted to excellent in RS3 (0.950, 95% confidence interval (CI): 0.936–0.962) from moderate in RS1 (0.674, 95% CI: 0.614–0.735) and RS2 (0.736, 95% CI: 0.683–0.789). The 2- and 4-category scoring accuracy were improved by 4.2% (0.959, 95% CI: 0.953–0.964) and 13% (0.815, 95% CI: 0.803–0.827) (p < 0.001). The AI results were generally accepted by pathologists with 61% “fully accepted” and 91% “almost accepted”. The proposed AI-assisted method can help pathologists at all levels to improve the PD-L1 assay (SP-142) IC assessment in breast cancer in terms of both accuracy and concordance. The AI tool provides a scheme to standardize the PD-L1 IC scoring in clinical practice.


Sign in / Sign up

Export Citation Format

Share Document